Category: Press Release

NEW YORK, Nov. 14, 2023 (GLOBE NEWSWIRE) —

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI) between August 15, 2022 and September 27, 2023, both dates inclusive (the “Class Period”), of the important January 2, 2024 lead plaintiff deadline. in the securities class action commenced by the Firm.

SO WHAT: If you purchased Brainstorm Cell securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Brainstorm Cell class action, go to https://rosenlegal.com/submit-form/?case_id=19375 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than January 2, 2024. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Many of these firms do not actually litigate securities class actions. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, throughout the Class Period defendants made materially false and/or misleading statements and/or failed to disclose that: (1) Brainstorm Cell downplayed the severity of the U.S. Food and Drug Administration’s (“FDA”) refusal to file letter; (2) Brainstorm Cell continued to conceal the risks associated with the submission of the biologics license application (“BLA”); and (3) as a result, defendants’ statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Brainstorm Cell class action, go to https://rosenlegal.com/submit-form/?case_id=19375 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm.

Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm’s attorneys are ranked and recognized by numerous independent and respected sources. Rosen Law Firm has secured hundreds of millions of dollars for investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

——————————–

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40^th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
cases@rosenlegal.com
www.rosenlegal.com

GlobeNewswire Distribution ID 8979521

NEW YORK, Nov. 14, 2023 (GLOBE NEWSWIRE) —

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Advance Auto Parts, Inc. (NYSE: AAP) between November 16, 2022 and May 30, 2023, both dates inclusive (the “Class Period”), of the important December 8, 2023 lead plaintiff deadline.

SO WHAT: If you purchased Advance Auto securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Advance Auto class action, go to https://rosenlegal.com/submit-form/?case_id=19738 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than December 8, 2023. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants made materially false and/or misleading statements that: (1) misrepresented the efficacy of Advance Auto’s strategic pricing initiative and the impact of price reductions; (2) omitted and/or concealed the negative impacts of the pricing initiative; (3) provided investors with an overly optimistic perception of Advance Auto’s operations; and (4) created the false impression that inflation and macroeconomic factors had an insubstantial impact on Advance Auto’s margins. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Advance Auto class action, go to https://rosenlegal.com/submit-form/?case_id=19738 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

——————————–

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
cases@rosenlegal.com
www.rosenlegal.com

GlobeNewswire Distribution ID 8979466

NEW YORK, Nov. 14, 2023 (GLOBE NEWSWIRE) —

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of AdaptHealth Corp. (NASDAQ: AHCO) between (1) August 4, 2020 and February 27, 2023, both dates inclusive (the “Class Period”) or (2) AdaptHealth common stock pursuant and/or traceable to the Company’s secondary public offering (the “SPO”) conducted on or around January 5, 2021, of the important December 26, 2023 lead plaintiff deadline.

SO WHAT: If you purchased AdaptHealth common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the AdaptHealth class action, go to https://rosenlegal.com/submit-form/?case_id=20167 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than December 26, 2023. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants made false and/or misleading statements because: (1) AdaptHealth misstated the Company’s true ability to generate organic growth in its diabetes segment; (2) AdaptHealth engaged in improper upcoding and other illicit billing practices; (3) that, as a result of the foregoing, certain of the defendants’ statements about the Company’s business, operations and prospects were materially misleading and/or lacked a reasonable basis.

Further, the lawsuit alleges the “SPO Offering Materials contained untrue statements of material fact, omitted material facts necessary to make the statements contained therein not misleading, and failed to make adequate disclosures required under the rules and regulations governing the preparation of such documents.” When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the AdaptHealth class action, go to https://rosenlegal.com/submit-form/?case_id=20167 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

——————————–

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
cases@rosenlegal.com
www.rosenlegal.com

GlobeNewswire Distribution ID 8979426

ISA proudly supports World Diabetes Day 2023 with its awareness campaign

BRUSSELS, Belgium, Nov. 14, 2023 (GLOBE NEWSWIRE) — The International Sweeteners Association (ISA) proudly renews its support to World Diabetes Day (WDD), organised each year on 14th November by the International Diabetes Federation (IDF) and in 2023 with the theme ‘Know your risk, know your response’.¹

1 in 10 adults worldwide, approximately 537 million people, have diabetes and half a billion more are at risk of developing type 2 diabetes.² Though, type 2 diabetes and its complications can be delayed or prevented by adopting and maintaining healthy habits, including following a balanced diet and being physically active. This is why the ISA joins the call to help increase awareness of diabetes risk and response.

Discover the latest nutritional guidelines for diabetes management
Knowing your risk of type 2 diabetes to help delay or prevent the condition is important. Knowing what to do and eat for better diabetes control is also vital! The ISA supports health professionals in staying informed of the latest evidence-based nutritional guidelines to inform discussions with patients on diabetes prevention and management. Hence, the ISA online campaign for World Diabetes Day 2023 aims to raise awareness about the importance of knowing what to eat for diabetes prevention and management, while sharing the latest nutritional guidelines for diabetes management and the recommendations for the intake of low/no calorie sweeteners in diabetes:

• Watch the ISA video presenting recent clinical practice and nutritional guidelines for diabetes management, including about low/no calorie sweeteners
• Download the new ISA factsheet for healthcare professionals on low/no calorie sweeteners in diabetes
• Discover chapter 5 of the ISA booklet dedicated to “Low/no calorie sweeteners, diabetes and cardiometabolic health”
• Join the ISA webinar organised together with the Brazilian Society for Food and Nutrition (Sociedade Brasileira de Alimentação e Nutrição – SBAN) on 1st December 2023 on the theme “Recommendations and regulation on the use of low/no calorie sweeteners: Global and Brazilian perspectives” (more information to be available soon).

Low/no calorie sweeteners as part of healthy diet for people with diabetes
Alongside other cornerstones of diabetes management, a healthy diet has the potential to improve glucose control, reduce the risk of diabetes complications and improve quality of life. Diabetes and nutrition-related organisations globally recognise that low/no calorie sweeteners can be safely used by people with diabetes to help reduce overall energy and sugars intake without affecting blood glucose control, and thus be a helpful strategy to aid with glycaemic control and weight management.^3-8 This was recognised, among others, in the “Evidence-based European recommendations for the dietary management of diabetes” updated in April 2023 by the Diabetes and Nutrition Study Group (DNSG) of the European Association for the Study of Diabetes (EASD)³ and by the American Diabetes Association (ADA) in their annually updated “Standards of Care in Diabetes” including the ADA’s current clinical practice and medical nutrition therapy recommendations.⁴

ISA activities for World Diabetes Day 2023 have been endorsed by diabetes organisations including the Brazilian diabetes association (ANAD)⁹, the Brazilian Association of Diabetes Educators (ANBED)¹⁰ and the Brazilian Federation of Diabetes Organisations (FENAD).¹¹

Share the ISA campaign for World Diabetes Day 2023 on social media with your friends, family and network by using the dedicated hashtags #ISA4WDD, #WorldDiabetesDay and #KnowYourRisk.

More information about ISA activities for World Diabetes Day is available here.

REFERENCES:

1. More information about World Diabetes Day 2023 is available on the WDD website available at: https://worlddiabetesday.org
2. IDF, Diabetes Atlas 10th edition 2021. Available at: https://diabetesatlas.org/atlas/tenth-edition/ (Accessed 20 October 2023)
3. Diabetes and Nutrition Study Group (DNSG) of the European Association for the Study of Diabetes (EASD). Evidence-based European recommendations for the dietary management of diabetes. Diabetologia. 2023 Jun;66(6):965-985. https://doi.org/10.1007/s00125-023-05894-8
4. ElSayed NA, Aleppo G, Aroda VR, et al, on behalf of the American Diabetes Association. 5. Facilitating Positive Health Behaviors and Well-being to Improve Health Outcomes: Standards of Care in Diabetes-2023. Diabetes Care. 2023 Jan 1;46(Supple 1):S68-S96. https://doi.org/10.2337/dc23-S005
5. Diabetes UK. The use of low or no calorie sweeteners. Position Statement (Updated December 2018). Available at: https://www.diabetes.org.uk/professionals/position-statements-reports/food-nutrition-lifestyle/use-of-low-or-no-calorie-sweetners (Accessed 20 October 2023)
6. Laviada-Molina H, Escobar-Duque ID, Pereyra E, et al. Consenso de la Asociación Latinoamericana de Diabetes sobre uso de edulcorantes no calóricos en personas con diabetes [Consensus of the Latin-American Association of Diabetes on low calorie sweeteners in persons with diabetes]. Rev ALAD. 2018;8:152-74.
7. Sievenpiper JL, Chan CB, Dworatzek PD, Freeze C, Williams SL. Diabetes Canada 2018 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada: Nutrition Therapy. Can J Diabetes. 2018;42(Suppl 1):S64-S79
8. MacLeod J, Franz MJ, Handu D, et al. Academy of Nutrition and Dietetics Nutrition Practice Guideline for Type 1 and Type 2 Diabetes in Adults: Nutrition Intervention Evidence Reviews and Recommendations. J Acad Nutr Diet. 2017;117(10):1637-1658
9. Associação Nacional de Atenção ao Diabetes
10. Associação Nacional Brasileira de Educadores em Diabetes
11. Federação Nacional de Associações e Entitades de Diabetes

ISA – Avenue de Tervueren 13A – Bte 7, B-1040 Brussels, Belgium – Tel: +32 (0)2 736 53 54 – Fax: +32 (0)2 732 34 27
E-mail: info@sweeteners.org – Website: www.sweeteners.org – TVA BE 424.301.259

GlobeNewswire Distribution ID 8979273

London, Nov. 14, 2023 (GLOBE NEWSWIRE) —  Pacific Green is happy to report that control of the first stage of the 99.8 MWh Richborough Battery Energy Park (“REP2”) has been handed over to Shell Energy Europe Limited (“Shell”) which will provide dispatch trading and optimisation services after testing is concluded.

During the w/c the 6th of November, all the REP2 testing and commissioning was successfully completed to the satisfaction of the National Grid and control of the asset was handed to Shell. The technical team at Shell, working alongside their energy trading colleagues, will complete the fine-tuning before entering the asset into commercial markets.

This is an important milestone toward full commercial operation scheduled to take place by the end of 2023 and marks the end of a successful development and construction process for the Battery Energy Storage project purchased from Pacific Green by Sosteno Fund 1 in June 2023.

Rupen Tanna, Head of Power and Systematic Trading, Shell Energy Europe Limited commented: “We are delighted to partner with Pacific Green to optimise the Richborough Battery Energy Park, one of the UK’s major battery projects. When operating at full capacity, it will play a crucial role in supporting the country’s transition to a flexible and low-carbon energy system.”

Scott Poulter, Pacific Green’s CEO commented: “Our team have been working closely with Shell engineers over a number of months and this marks the culmination of those efforts. We are excited to move into full operations and start delivering valuable support and stability services to a critical area of the UK’s transmission network. The Shell team has considerable experience in managing energy assets and we are pleased to pass the optimisation of the asset into their hands at the start of this 10 year contract”

About Pacific Green Technologies, Inc.:

Pacific Green is focused on addressing the world’s need for cleaner and more sustainable energy. It offers grid-scale battery energy storage systems, renewable and environmental technologies.

For more information, visit Pacific Green’s website:
www.pacificgreen.com

About Shell Energy Europe

Shell Energy Europe is present in 14 European power markets, offtaking renewable power from wind farms and solar parks in mainland Europe and the UK and providing business customers with innovative, reliable and cleaner energy solutions to help them navigate through the energy transition.

Shell Energy Europe Limited acts through its agent, Shell Trading and Shipping Company Limited.

Scott Poulter, Chairman & CEO
Pacific Green Technologies, Inc.
T: +1 (302) 601-4659

GlobeNewswire Distribution ID 8979113